Tesamorelin is a synthetic growth hormone-releasing factor analogue used therapeutically to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. By binding to the ghrelin receptor,… Read more
Tesamorelin is a synthetic growth hormone-releasing factor analogue used therapeutically to reduce excess abdominal fat in HIV-infected patients with lipodystrophy. By binding to the ghrelin receptor, this peptide stimulates the release of endogenous growth hormone to help manage body fat distribution. This category contains high-quality reference standards for Tesamorelin and its acetate salt, providing pharmaceutical laboratories with the essential materials required for rigorous analytical testing. These compounds, including specific impurities, degradation products, and stable isotope labelled versions of the molecule, are critical for method validation and comprehensive impurity profiling. Scientists and researchers rely on these certified materials to ensure the precision and reliability of quantitative analysis during stability testing and quality control procedures, facilitating compliance with regulatory requirements throughout the pharmaceutical manufacturing process.